Department of Urology, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-Cho, Sakyo-Ku, Kyoto, 606-8507, Japan.
Department of Urology, Japanese Red Cross Otsu Hospital, Otsu, Shiga, Japan.
Int J Clin Oncol. 2020 Jan;25(1):126-134. doi: 10.1007/s10147-019-01533-8. Epub 2019 Aug 30.
Because of the small numbers of cases in single centers, the indications for and survival benefits of adrenalectomy for adrenal metastasis remain unclear. We evaluated the outcomes of laparoscopic adrenalectomy for patients with adrenal metastasis.
We retrospectively analyzed the records of 67 patients who underwent laparoscopic adrenalectomy for metastatic disease from 2003 to 2017 at 11 hospitals. Associations of clinical, surgical, and pathologic features with overall survival (OS) and positive surgical margins were evaluated using univariate and multivariate Cox regression analyses and univariate logistic regression analysis.
Lung cancer (30%) and renal cell carcinoma (30%) were the most common primary tumor types. Intraoperative complications were observed in seven patients (10%) and postoperative complications in seven (10%). The surgical margin was positive in 10 patients (15%). The median OS was 3.8 years. Univariate analysis showed that the tumor size, episodes of extra-adrenal metastasis before adrenalectomy, extra-adrenal metastasis at the time of adrenalectomy, and positive surgical margins were significantly associated with shorter OS (p = 0.022, p = 0.005, p < 0.001, and p = 0.022, respectively). Multivariate analysis showed that extra-adrenal metastasis at the time of adrenalectomy and positive surgical margins remained statistically significant (p = 0.022 and p = 0.049, respectively). In the univariate analysis, the tumor size was significantly associated with positive surgical margins (p = 0.039).
Laparoscopic adrenalectomy for adrenal metastasis can be safely performed in selected patients, and patients with isolated adrenal metastasis and negative surgical margins seem to have more favorable outcomes.
由于单中心病例数量较少,因此肾上腺切除术治疗肾上腺转移的适应证和生存获益仍不清楚。我们评估了腹腔镜肾上腺切除术治疗肾上腺转移患者的结果。
我们回顾性分析了 2003 年至 2017 年 11 家医院 67 例因转移性疾病行腹腔镜肾上腺切除术患者的记录。使用单因素和多因素 Cox 回归分析以及单因素逻辑回归分析评估临床、手术和病理特征与总生存(OS)和阳性手术切缘之间的关系。
肺癌(30%)和肾细胞癌(30%)是最常见的原发肿瘤类型。7 例(10%)患者术中出现并发症,7 例(10%)患者术后出现并发症。10 例(15%)患者的手术切缘阳性。中位 OS 为 3.8 年。单因素分析显示,肿瘤大小、肾上腺切除术前行肾上腺外转移次数、肾上腺切除术时发生肾上腺外转移和阳性手术切缘与较短的 OS 显著相关(p=0.022、p=0.005、p<0.001 和 p=0.022)。多因素分析显示,肾上腺切除术时发生肾上腺外转移和阳性手术切缘仍具有统计学意义(p=0.022 和 p=0.049)。单因素分析显示,肿瘤大小与阳性手术切缘显著相关(p=0.039)。
在选择的患者中,腹腔镜肾上腺切除术治疗肾上腺转移是安全的,且孤立性肾上腺转移和阴性手术切缘的患者似乎具有更好的结果。